Cargando…

Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center

The severity of clinical features and the outcomes in previous series of patients reported with Henoch-Schönlein purpura (HSP) vary greatly, probably due to selection bias. To establish the actual clinical spectrum of HSP in all age groups using an unselected and wide series of patients diagnosed at...

Descripción completa

Detalles Bibliográficos
Autores principales: Calvo-Río, Vanesa, Loricera, Javier, Mata, Cristina, Martín, Luis, Ortiz-Sanjuán, Francisco, Alvarez, Lino, González-Vela, M. Carmen, González-Lamuño, Domingo, Rueda-Gotor, Javier, Fernández-Llaca, Héctor, González-López, Marcos A., Armesto, Susana, Peiró, Enriqueta, Arias, Manuel, González-Gay, Miguel A., Blanco, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616305/
https://www.ncbi.nlm.nih.gov/pubmed/24646467
http://dx.doi.org/10.1097/MD.0000000000000019
_version_ 1782396602880622592
author Calvo-Río, Vanesa
Loricera, Javier
Mata, Cristina
Martín, Luis
Ortiz-Sanjuán, Francisco
Alvarez, Lino
González-Vela, M. Carmen
González-Lamuño, Domingo
Rueda-Gotor, Javier
Fernández-Llaca, Héctor
González-López, Marcos A.
Armesto, Susana
Peiró, Enriqueta
Arias, Manuel
González-Gay, Miguel A.
Blanco, Ricardo
author_facet Calvo-Río, Vanesa
Loricera, Javier
Mata, Cristina
Martín, Luis
Ortiz-Sanjuán, Francisco
Alvarez, Lino
González-Vela, M. Carmen
González-Lamuño, Domingo
Rueda-Gotor, Javier
Fernández-Llaca, Héctor
González-López, Marcos A.
Armesto, Susana
Peiró, Enriqueta
Arias, Manuel
González-Gay, Miguel A.
Blanco, Ricardo
author_sort Calvo-Río, Vanesa
collection PubMed
description The severity of clinical features and the outcomes in previous series of patients reported with Henoch-Schönlein purpura (HSP) vary greatly, probably due to selection bias. To establish the actual clinical spectrum of HSP in all age groups using an unselected and wide series of patients diagnosed at a single center, we performed a retrospective review of 417 patients classified as having HSP according to the criteria proposed by Michel et al. Of 417 patients, 240 were male and 177 female, with a median age at the time of disease diagnosis of 7.5 years (interquartile range [IQR], 5.3–20.1 yr). Three-quarters of the patients were children or young people aged 20 years or younger (n = 315), and one-quarter were adults (n = 102). The most frequent precipitating events were a previous infection (38%), usually an upper respiratory tract infection, and/or drug intake (18.5%) shortly before the onset of the vasculitis. At disease onset the most common manifestations were skin lesions (55.9%), nephropathy (24%), gastrointestinal involvement (13.7%), joint symptoms (9.1%), and fever (6.2%). Cutaneous involvement occurring in all patients, mainly purpuric skin lesion, was the most common manifestation when the vasculitis was fully established, followed by gastrointestinal (64.5%), joint (63.1%), and renal involvement (41.2%). The main laboratory findings were leukocytosis (36.7%), anemia (8.9%), and increased serum IgA levels (31.7%). The most frequent therapies used were corticosteroids (35%), nonsteroidal antiinflammatory drugs (14%), and cytotoxic agents (5%). After a median follow-up of 12 months (IQR, 2–38 mo), complete recovery was observed in most cases (n = 346; 83.2%), while persistent, usually mild, nephropathy was observed in only 32 (7.7%) cases. Relapses were observed in almost a third of patients (n = 133; 31.9%). In conclusion, although HSP is a typical vasculitis affecting children and young people, it is not uncommon in adults. The prognosis is favorable in most cases, depending largely on renal involvement.
format Online
Article
Text
id pubmed-4616305
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-46163052015-10-27 Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center Calvo-Río, Vanesa Loricera, Javier Mata, Cristina Martín, Luis Ortiz-Sanjuán, Francisco Alvarez, Lino González-Vela, M. Carmen González-Lamuño, Domingo Rueda-Gotor, Javier Fernández-Llaca, Héctor González-López, Marcos A. Armesto, Susana Peiró, Enriqueta Arias, Manuel González-Gay, Miguel A. Blanco, Ricardo Medicine (Baltimore) Original Study The severity of clinical features and the outcomes in previous series of patients reported with Henoch-Schönlein purpura (HSP) vary greatly, probably due to selection bias. To establish the actual clinical spectrum of HSP in all age groups using an unselected and wide series of patients diagnosed at a single center, we performed a retrospective review of 417 patients classified as having HSP according to the criteria proposed by Michel et al. Of 417 patients, 240 were male and 177 female, with a median age at the time of disease diagnosis of 7.5 years (interquartile range [IQR], 5.3–20.1 yr). Three-quarters of the patients were children or young people aged 20 years or younger (n = 315), and one-quarter were adults (n = 102). The most frequent precipitating events were a previous infection (38%), usually an upper respiratory tract infection, and/or drug intake (18.5%) shortly before the onset of the vasculitis. At disease onset the most common manifestations were skin lesions (55.9%), nephropathy (24%), gastrointestinal involvement (13.7%), joint symptoms (9.1%), and fever (6.2%). Cutaneous involvement occurring in all patients, mainly purpuric skin lesion, was the most common manifestation when the vasculitis was fully established, followed by gastrointestinal (64.5%), joint (63.1%), and renal involvement (41.2%). The main laboratory findings were leukocytosis (36.7%), anemia (8.9%), and increased serum IgA levels (31.7%). The most frequent therapies used were corticosteroids (35%), nonsteroidal antiinflammatory drugs (14%), and cytotoxic agents (5%). After a median follow-up of 12 months (IQR, 2–38 mo), complete recovery was observed in most cases (n = 346; 83.2%), while persistent, usually mild, nephropathy was observed in only 32 (7.7%) cases. Relapses were observed in almost a third of patients (n = 133; 31.9%). In conclusion, although HSP is a typical vasculitis affecting children and young people, it is not uncommon in adults. The prognosis is favorable in most cases, depending largely on renal involvement. Lippincott Williams & Wilkins 2014-03-04 /pmc/articles/PMC4616305/ /pubmed/24646467 http://dx.doi.org/10.1097/MD.0000000000000019 Text en Copyright © 2014 by Lippincott Williams & Wilkins
spellingShingle Original Study
Calvo-Río, Vanesa
Loricera, Javier
Mata, Cristina
Martín, Luis
Ortiz-Sanjuán, Francisco
Alvarez, Lino
González-Vela, M. Carmen
González-Lamuño, Domingo
Rueda-Gotor, Javier
Fernández-Llaca, Héctor
González-López, Marcos A.
Armesto, Susana
Peiró, Enriqueta
Arias, Manuel
González-Gay, Miguel A.
Blanco, Ricardo
Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center
title Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center
title_full Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center
title_fullStr Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center
title_full_unstemmed Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center
title_short Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center
title_sort henoch-schönlein purpura in northern spain: clinical spectrum of the disease in 417 patients from a single center
topic Original Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616305/
https://www.ncbi.nlm.nih.gov/pubmed/24646467
http://dx.doi.org/10.1097/MD.0000000000000019
work_keys_str_mv AT calvoriovanesa henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter
AT loricerajavier henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter
AT matacristina henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter
AT martinluis henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter
AT ortizsanjuanfrancisco henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter
AT alvarezlino henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter
AT gonzalezvelamcarmen henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter
AT gonzalezlamunodomingo henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter
AT ruedagotorjavier henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter
AT fernandezllacahector henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter
AT gonzalezlopezmarcosa henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter
AT armestosusana henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter
AT peiroenriqueta henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter
AT ariasmanuel henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter
AT gonzalezgaymiguela henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter
AT blancoricardo henochschonleinpurpurainnorthernspainclinicalspectrumofthediseasein417patientsfromasinglecenter